Apotheek Malem SRL
Apotheek Malem reported total assets of 326,258 € at the end of the 2024 financial year (annual accounts filed with the NBB on 25 Jul 2025).
The score of Apotheek Malem shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +42 % Total assets +27 %
Accounts of the company itself (not consolidated).
The full file covers 13 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Malem's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | 18,576 € | ||||
| Equity | 196,626 € | ||||
| Cash | 113,652 € | ||||
| EBITDA | 59,548 € | ||||
| Total assets | 326,258 € |
Filed annual accounts
- Year ended 31 Dec 2024filed on 25 Jul 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 20 Jun 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
- Year ended 31 Dec 2020filed on 01 Sep 2021
Apotheek Malem's financial analysis
- Solvency60.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Malem
Apotheek Malem's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0428.384.464
- VAT number
- BE0428384464
- Peppol
- Registered · 0208:0428384464 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Dec 1985
- Registered office
- 9000 Ghent
- Latest accounts
- 2024 · filed on 25 Jul 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Malem (SRL) has been based in Ghent since 1985, active in: retail sale of pharmaceutical products. For 2024, it reports a net profit of 18,576 € and equity of 196,626 €; its revenue is not published. Its solvency stands at 60.3%, above the median of its sector (44.2%).
Companies similar to Apotheek Malem
Companies in the same business, of comparable size and area, outside its group.
- Verapharm Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 327,020 €
- Medi Falcon Retail sale of pharmaceutical products Aalst · balance sheet 328,898 €
- Geassocieerde Apotheek Ekeren Retail sale of pharmaceutical products Antwerp · balance sheet 331,202 €
- Milan Apotica Retail sale of pharmaceutical products Waterloo · balance sheet 321,144 €
- Pharma-Thuillies Retail sale of pharmaceutical products Thuin · balance sheet 400,573 €
- Apoteek DE Smedt Retail sale of pharmaceutical products Asse · balance sheet 343,684 €
- Vision 2017 Retail sale of pharmaceutical products Schaerbeek · balance sheet 318,760 €
- Phardec Retail sale of pharmaceutical products Koekelberg · balance sheet 335,635 €
Frequently asked questions about Apotheek Malem
What is the revenue of Apotheek Malem?
Apotheek Malem files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Apotheek Malem?
In Belgium, the VAT number is the company number prefixed with BE: BE0428384464 for Apotheek Malem, if the company is VAT-registered. Its company number (CBE) is 0428.384.464.
Where is the registered office of Apotheek Malem?
According to the CBE register, the registered office of Apotheek Malem is in 9000 Ghent.
What is the equity of Apotheek Malem?
At the close of the 2024 financial year, the equity of Apotheek Malem amounts to 196,626 €, a solvency of 60.3% of total assets.
Who manages Apotheek Malem?
The register lists 1 active mandates at Apotheek Malem. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Malem
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →